Unknown

Dataset Information

Multiobjective optimization identifies cancer-selective combination therapies.


ABSTRACT: Combinatorial therapies are required to treat patients with advanced cancers that have become resistant to monotherapies through rewiring of redundant pathways. Due to a massive number of potential drug combinations, there is a need for systematic approaches to identify safe and effective combinations for each patient, using cost-effective methods. Here, we developed an exact multiobjective optimization method for identifying pairwise or higher-order combinations that show maximal cancer-selectivity. The prioritization of patient-specific combinations is based on Pareto-optimization in the search space spanned by the therapeutic and nonselective effects of combinations. We demonstrate the performance of the method in the context of BRAF-V600E melanoma treatment, where the optimal solutions

SUBMITTER: Pulkkinen OI 

PROVIDER: S-EPMC7793282 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature